Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (505)

« Back to Publications

Reply to: Methodological Issues in Taquet et al.'s analysis preclude any conclusions regarding AS01 adjuvant's specific role in dementia prevention.

Taquet M. et al, (2025), NPJ Vaccines, 10

Neural signatures of risk-taking adaptions across health, bipolar disorder, and lithium treatment.

Scholl J. et al, (2025), Mol Psychiatry, 30, 2955 - 2965

Lower risk of dementia with AS01-adjuvanted vaccination against shingles and respiratory syncytial virus infections.

Taquet M. et al, (2025), NPJ Vaccines, 10

Can liaison neurology add value to patient care within a mental health setting?

Ward JH. et al, (2025), Br J Psychiatry, 226, 47 - 48

The recombinant shingles vaccine is associated with lower risk of dementia.

Taquet M. et al, (2024), Nat Med, 30, 2777 - 2781

Association between a selective 5-HT4 receptor agonist and incidence of major depressive disorder: emulated target trial.

de Cates AN. et al, (2024), Br J Psychiatry, 225, 371 - 378

Cognitive and psychiatric symptom trajectories 2-3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK.

Taquet M. et al, (2024), Lancet Psychiatry, 11, 696 - 708

12-month neurological and psychiatric outcomes of semaglutide use for type 2 diabetes: a propensity-score matched cohort study.

De Giorgi R. et al, (2024), EClinicalMedicine, 74

Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury.

Taquet M. et al, (2024), Brain Commun, 6

Data-Driven Taxonomy for Antipsychotic Medication: A New Classification System.

McCutcheon RA. et al, (2023), Biol Psychiatry, 94, 561 - 568

Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization.

Taquet M. et al, (2023), Nat Med, 29, 2498 - 2508

GRIN2A (NR2A): a gene contributing to glutamatergic involvement in schizophrenia.

Harrison PJ. and Bannerman DM., (2023), Mol Psychiatry, 28, 3568 - 3572

Sex and age effects on risk of non-traumatic subarachnoid hemorrhage: Retrospective cohort study of 124,234 cases using electronic health records.

Harrison CH. et al, (2023), J Stroke Cerebrovasc Dis, 32

Neuropsychiatric disorders following SARS-CoV-2 infection.

Harrison PJ. and Taquet M., (2023), Brain, 146, 2241 - 2247

Neural signatures of risk-taking adaptions across health, bipolar disorder, and lithium treatment

Scholl J. et al, (2023)

Load More

1
2
3
4
5
6
7
...
»